Mycophenolate mofetil Withdrawn Phase 2 Trials for LPL Deficiency Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02904772Alipogene Tiparvovec for the Treatment of LPLD Patients